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Summary
Background Models that incorporate patterns of multiple cytokine responses to allergens,
rather than individual cytokine production, may better predict sensitization and asthma.
Objective To characterize the patterns of peripheral blood mononuclear cells’ (PBMCs)
cytokine responses to house dust mite (HDM) allergens among children from two popula-
tion-based birth cohorts using machine learning techniques.
Methods PBMCs collected at 8 years of age from the UK Manchester Asthma and Allergy
Study (n = 268) and at 14 years of age from the Australian Raine Study (n = 1374) were
cultured with HDM extract (10 lg/ml). Cytokine expression (IL-13, IL-5, IFN-c, and IL10)
was measured in the supernatant. Cytokine patterns were identified using a Gaussian mix-
ture model clustering, and classification stability was assessed by bootstrapping.
Results A six-class model indicated complex latent structure of cytokine expression.
Based on the characteristics of each class, we designated them as follows: ‘Nonresponders’
(n = 905, 55%); ‘IL-10 responders’ (n = 49, 3%); ‘IFN-c and IL-13 medium responders’
(n = 56, 3.4%); ‘IL-13 medium responders’ (n = 351, 21.4%); ‘IL-5 and IL-13 medium
responders’ (n = 77, 4.7%); and ‘IL-13 and IL-5 high responders’ (n = 204, 12.4%). ‘IL-13
and IL-5 high responders’ were at much higher risk of HDM sensitization and asthma
compared to all other classes, with 88% of children assigned to this class being sensitized
and 28.5% having asthma.
Conclusion Using model-based clustering, we identified several distinct patterns of cyto-
kine response to HDM and observed interplay between cytokine expression level, cytokine
patterns (especially IL-13 and IL-5), and clinical outcomes. ‘IL-13 and IL-5 high respond-
ers’ class was strongly associated with HDM sensitization. However, among HDM-sensi-
tized children, one-third showed no PBMC response to HDM, and the majority of HDM-
sensitized children did not have asthma or wheeze. Our findings suggest that positive
HDM ‘allergy tests’ and asthma are associated with a broad range of immunophenotypes,
which may have important implications for the use of cytokine-targeted treatment
approaches.
Keywords asthma, cytokine pattern, house dust mite allergens, MAAS, Raine Study, sensi-
tization
Submitted 18 November 2014; revised 17 March 2015; accepted 25 April 2015
Introduction
Sensitization to house dust mite (HDM) allergens is a
strong risk factor for childhood asthma, and the titre of
HDM-specific IgE (sIgE) antibodies is a good predictor
of asthma presence and persistence [1, 2]. However,
*Equal contribution
†These authors are joint senior authors
sensitization is neither necessary nor sufficient for dis-
ease expression [3]. Among other contributing mecha-
nisms, the expression of asthma may be in part
determined by the T-cell immunity to inhalant allergens
[4]. In our previous studies characterizing immune
responses of peripheral blood mononuclear cells
(PBMCs), we have reported that responses to HDM aller-
gens among asthmatic children are heterogeneous, even
within the seemingly homogeneous group of children
with atopic asthma [5].
Most previous studies evaluated the relationship
between individual cytokine responses of PBMCs to
mite allergens with clinical outcomes [6, 7]. We propose
that models that incorporate the patterns of multiple
cytokine responses, rather than individual cytokine pro-
duction, may give a more accurate reflection of the
underlying biological processes and better predict the
presence of sensitization and wheezing/asthma. Recent
developments in machine learning (a data-driven
approach to identify structure within the data using
unsupervised learning of latent variables) provide new
ways to capture the heterogeneity in patterns of
responses to multiple items. Machine learning is
increasingly used to disaggregate complex phenotypes
in respiratory medicine and allergy [8–15], where con-
ventional modelling techniques might not uncover the
underlying complexity [16].
We hypothesize that there are multiple immunophe-
notypes of T-cell immunity to HDM allergens which
differ in their relation to mite sensitization and asthma
and that machine learning may facilitate better under-
standing of the patterns of cytokine responses and help
identify such immunophenotypes. To address our
hypotheses, we characterized the patterns of cytokine
responses to HDM allergens using machine learning
techniques among children from two large population-
based birth cohorts studied independently in two geo-
graphical areas (UK and Australia), amounting to >1600
subjects in whom we measured T-cell responses.
Methods
Study design, setting, and participants
We studied two population-based birth cohorts, the
Manchester Asthma and Allergy Study (MAAS; IS-
RCTN72673620) [17–19] and the Western Australia
Pregnancy Cohort (Raine) Study [20]. Both studies were
approved by local research ethics committees. Informed
consent was obtained from all parents, and children
gave their assent if appropriate.
Manchester, UK. MAAS participants were recruited pre-
natally. Children were followed prospectively and
attended review clinic with a clinical assessment and
blood collection for cellular studies at eight years of
age.
Perth, Western Australia. The Raine Study recruited
subjects from public antenatal clinics at King Edward
Memorial Hospital and nearby private practices. Chil-
dren were followed prospectively, with a clinical assess-
ment and blood collection at 14 years of age.
Data sources
Identical validated questionnaires were administered in
both cohorts to collect information on parentally
reported symptoms, physician-diagnosed diseases and
treatments received [21, 22]. We ascertained HDM
sensitization by skin prick testing (SPT; Stallergenes,
Hauts-de-Seine, France) and measurement of HDM-
specific IgE levels using ImmunoCAPTM (Phadia AB,
Uppsala, Sweden).
Definition of variables
Clinical outcomes were defined at eight years of age
(UK) and at 14 years of age (Australia).
Current wheeze. A positive response to the question
‘Has your child had wheezing or whistling in the chest
in the last 12 months?’
Current asthma. All three of the following: 1) Current
wheeze; 2) current use of asthma medication; and 3)
physician-diagnosed asthma ever.
Mite sensitization, SPT. Mean HDM SPT wheal diameter
≥3 mm.
Mite sensitization, IgE. HDM-specific IgE > 0.35 kU/L.
Cellular studies
Cryopreserved PBMCs from Manchester were shipped to
Perth for analysis. Although the assays for the two
cohorts were not performed simultaneously, the assays
were tightly standardized and quality controlled to allow
accurate comparison. Coefficients of variation for both
cohorts are shown in Table S3. We used identical proto-
cols for in vitro studies in both cohorts; the methods are
described in detail in our previous studies [5, 20, 23, 24].
Briefly, PBMC were cultured for 48 h in AIM-V medium
containing 2-mercaptoethanol (50 lM) alone (medium
control), with phytoheamagglutinin (PHA, 1 lg/ml,
positive control), or with HDM (Dermatophagoides pter-
onyssinus) extract (10 lg/ml) which was prepared
in-house, with a single batch used for the whole study
(endotoxin level was not quantified). This stimulation
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time (48 h) was validated in our previous studies [5, 20,
23–25]. IL-5, IL-10, IL-13 and interferon (IFN)-c protein
in supernatants were assayed using time-resolved fluo-
rescence as previously described [20]. The limit of detec-
tion was 10 pg/ml for all cytokines reported in this
study. The cytokine response to HDM and PHA was cal-
culated by subtracting the corresponding value from the
medium control. Data from PBMC cultures for 16 chil-
dren were excluded from this analysis – six samples
from Raine Study had inadequate viable PBMC numbers
for culture, and 10 samples from MAAS study were
excluded due to negative response to PHA.
Statistical methods
Data were modelled separately for each cohort and
jointly across the two cohorts.
Cytokine class model. Among children with complete
data, only those with at least one positive cytokine
assay were included in the analysis (nMAAS = 119,
nRAINE = 618). As the distributions of the cytokine val-
ues from either cohort were highly skewed, data were
transformed (discretized) before clustering. Three types
of discretization were performed and tested: binary
(positive responder and negative responders); tertile
(negative responder, low and high responders); and
quartile (negative responder, low, medium, and high
responders). Selection of the best discretization method
was determined by the overall stability of the cluster
structure and the ability of the cluster in exposing most
information about the structure of the data set.
Cytokine patterns were identified using a Gaussian
mixture model clustering, optimizing parameters by
means of the expectation maximization algorithm [26],
where the optimal number of clusters was decided by
cross-validation, using the Weka software suite (http://
www.cs.waikato.ac.nz/ml/weka/). Model robustness,
both in terms of overall clustering structure stability
and single cluster support, was analysed by bootstrap
analysis (100 times using the R software (http://www.r-
project.org/), using the RWeka and e1071 packages).
Overall clustering stability was evaluated by calculating
the distribution of clustering agreement, measured via
the adjusted rand index, a measure of the similarity
between two data clusterings, adjusted for the chance
grouping of elements [27]. The single cluster support
was determined by a hard criterion that counted the
relative frequency of a cluster being the same (i.e. as
determined by the children assigned to it) over all the
bootstrap runs.
For each child, we computed a distribution giving the
probability of their belonging in each class; for further
analysis, we assumed the child belonged to the highest
probability class.
Association analysis. We then investigated the associa-
tion between the clinical outcomes and the cytokine
levels and the classes we had inferred using the Mann–
Whitney U-test and logistic regression analysis. We
present the results as the main effect with 95% confi-
dence intervals (CI). Both unadjusted P-values and
P-values adjusted using the Bonferroni correction are
shown.
Results
Participant flow, demographic characteristics and
descriptive data
Participant flow is shown in Fig. 1. Of 1184 children
born into the MAAS, PBMCs were available for 302; 24
samples had damage to cells as a result of shipping,
and a further 10 failed quality control tests (negative
PBMC responses to PHA), leaving 268 children with a
complete data set. Of these, 58 (21.6%) reported current
wheezing, 32 (11.9%) had current asthma, and 58
(21.9%) were sensitized to HDM (Table S1). In the Raine
cohort, six samples did not have viable PBMCs for cul-
ture and were excluded, and a total of 1374 adolescents
had complete data comprising questionnaires and cyto-
kine assays (Fig. 1). Of these, 179 (13.4%) reported cur-
rent wheezing, 140 (10.5%) had asthma, and 399
(30.1%) were mite sensitized (Table S1). There were no
significant differences in demographic characteristics or
any of the outcomes between the children who were
included and excluded from this analysis (Table S2).
HDM-induced cytokine expression. The proportion of
children with positive cytokine responses and the cyto-
kine levels in two cohorts are shown in Table S3. IL-5
and IL-13 levels were correlated within each cohort
(R2 > 0.35), with no significant correlation for other
cytokines. The relationship between cytokine levels and
clinical outcomes in the two cohorts is shown in
Table 1. Expression of IL-5 and IL-13 was significantly
higher among children with asthma, wheeze or mite
sensitization compared to those without these features
(P < 0.001). For IFN-c and IL-10, levels were signifi-
cantly higher among mite-sensitized than nonsensitized
children, but there were no difference between children
with or without wheeze or asthma.
Cytokine clustering and characterization of the cytokine
classes
The choice of the optimum data transformation (discret-
ization). We performed initial analyses in the two
cohorts separately. We carried out the analyses using
three different transformations of the data set (binary,
tertiles, quartiles; Tables S4, S5). The robustness of the
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binary solution was low (ARI score from bootstrapping;
ARIMAAS: 0.2, ARIRAINE: 0.46). In contrast, clusters gen-
erated from tertile- and quartile-discretized data had
similar structure and high stability (ARIMAAS: 0.48–
0.55, ARIRAINE: 0.66–0.68). Tertile discretization showed
higher robustness of the clusters than that from the
quartile discretization, and we observed similar patterns
across the two cohorts (Tables S4, S5). We therefore
discretized the combined data sets into tertiles before
performing joint clustering.
Cytokine classes identified. Children negative for all
cytokines were a priori assigned to Class 0 (‘Nonre-
sponder’, n = 905, 55%). We then applied the Gaussian
mixture model clustering to all data from children with
a positive response for at least one cytokine (n = 737).
The optimal model that best described the combined
data sets was a five-class model (Table S6, ARI = 0.85).
The distribution of children across the five cytokine
classes was comparable between MAAS and Raine
(Table S6). Based on our interpretation of their charac-
teristics (Figs 2 and 3), we assigned the classes as:
Class 1, ‘IL-10 responder’ (n = 49, 3%). All children
in this class produced IL-10 (Fig. 2a), with 20 also
producing IL-13 and ten producing IFN-c; none of
MAAS study: 1184 children 
recruited to the age 8 study
268 have full 
cytokine data
302 children have PBMC 
samples
10 subjects failed 
control test for 
cytokine assays 
882 children do not 
have PBMC samples
Cytokine assays were 
performed on 278 children
24 samples did not 
survive the shipment
Raine study: 1839 children 
recruited to the age 14 study
1374 have full 
cytokine data
1380 children have 
PBMC samples
459 children do 
not have PBMC 
samples
6 samples did not 
have enough viable 
cells
Total 1642 in the 
combined dataset
Fig. 1. Consort figure showing participant flow in MAAS and RAINE.
Table 1. Cytokine expression level from merged cohort by clinical outcomes
MAAS &
RAINE
Current asthma Current wheeze Mite sensitization (SPT) Mite sensitization (IgE)
Mean
rank P value
Adjusted P
value
Mean
rank P value
Adjusted P
value
Mean
rank
P
value
Adjusted P
value
Mean
rank P value
Adjusted P
value
IL-5
No 773.68 <0.001 <0.001 771.80 <0.001 <0.001 693.54 <0.001 <0.001 682.74 <0.001 <0.001
Yes 1008.81 962.09 1042.41 1014.81
IL-13
No 772.73 <0.001 <0.001 770.92 <0.001 <0.001 684.29 <0.001 <0.001 663.70 <0.001 <0.001
Yes 1016.64 967.14 1065.28 1047.05
IL-10
No 795.49 0.25 1.000 802.79 0.45 1.000 766.01 <0.001 <0.001 762.43 <0.001 <0.001
Yes 828.07 783.97 863.21 879.80
IFN-c
No 791.97 0.02 1.000 800.35 0.93 1.000 756.39 <0.001 <0.001 755.27 <0.001 <0.001
Yes 857.27 797.98 886.98 891.94
P values were calculated by Mann–Whitney test.
Adjusted P value were calculated by Bonferroni correction.
© 2015 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd., 45 : 1801–1811
1804 J. Wu et al
the children in this class expressed IL-5 (Figs 3a
and b).
Class 2, ‘IFN-c and IL-13 medium responder’
(n = 56, 3.4%). All children in this class produced
IFN-c (Fig. 2b), and the majority (n = 37) also pro-
duced IL-13, but not IL-5 (Figs 3 and b).
Class 3, ‘IL-13 medium responder’ (n = 351,
21.4%). All children produced IL-13, but only few
produced other three cytokines (Figs 2c and 3a–d).
Class 4, ‘IL-5 and IL-13 medium responder’ (n = 77,
4.7%). The majority of children assigned to this class
co-expressed IL-13 and IL-5 (n = 43), with only few
(n = 5) producing IFN-c or IL-10 (Fig. 2d). There
were no IFN-c and IL-10 co-expressers (Figs 3c
and d).
Class 5, ‘IL-13 and IL-5 high responder’ (n = 204,
12.4%). The majority of children in this class
(n = 188) co-expressed IL-13 and IL-5, and 141 also
produced IFN-c or IL-10 (Fig. 2e). Children in this
class produced the highest levels of IL-13 and IL-5
(Figs 3a and b).
Cytokine classes and clinical outcomes
The association between cytokine classes and clinical
outcomes is presented in Table 2. Although some chil-
dren in Class 1 and Class 2 produced IL-13, the clinical
outcomes in these two classes were not significantly
different from the ‘Nonresponders’ in Class 0.
By investigating classes 3, 4, and 5, we observed
interplay between cytokine expression level, cytokine
patterns (especially IL-13 and IL-5), and clinical out-
comes. Children in Class 3 (moderate IL-13 production
in response to HDM allergen) were at a modest risk of
mite sensitization compared to Class 0 (OR 2.93, 95% CI
2.24–3.81, P < 0.001), but did not differ significantly
from Class 0 in relation to wheeze or asthma (P = 0.53
and 0.38, respectively).
The expression of IL-13 seemed to be the prerequisite
for IL-5 expression, as children who produced IL-5, but
not IL-13, were rare (part of Class 4, <2% of study pop-
ulation). The majority of children who produced IL-5
(in classes 4 and 5) had accompanying high-level
expression of IL-13 (relative to Class 3), and high levels
of IL-5 were associated with high prevalence of asthma,
wheeze and mite sensitization (Table 2, classes 4 and
5).
Children in Class 5 were at a considerably higher risk
of mite sensitization (OR 25.02, 95% CI 15.87–39.45),
with 88% of children assigned to this class being sensi-
tized (IgE). The absolute levels of mite-specific IgE were
significantly higher in Class 5 compared to other four
classes, both in the whole group and among sensitized
children only (Fig. 4, P < 0.001). However, despite the
fact that most children in Class 5 were mite sensitized
and that this class was strongly associated with asthma
(OR 4.93, 95% CI 3.41–7.11) and wheeze (OR 5.49, 95%
3.62–8.33), the majority of children in this class did not
have asthma or wheeze (71.5% and 65%, respectively,
(a) (b)
(d) (e)
(c)
Fig. 2. Cytokine expression pattern of individual cytokine class (a–e). Scatter plot showing cytokine expression pattern within each cytokine
classes.
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Fig. S1). At the population level, the majority of chil-
dren who were sensitized to mite, or had asthma or
wheezing, came from Class 0 (Table S7).
Discussion
Key results
To our knowledge, this is the first study to analyse pat-
terns of PBMC cytokine responses to HDM allergens
in vitro by applying unsupervised machine learning
methodologies to jointly model the data, rather than
investigate associations for each cytokine separately.
We identified five distinct cytokine response classes to
the four cytokines we measured (IL-5, IL-10, IL-13, and
IFN-c) in children from two population-based birth
cohorts. These classes differed significantly in their
association with HDM-specific sensitization, asthma,
and wheeze. We observed different associations for
wheeze/asthma compared to HDM sensitization.
Limitations
We acknowledge that this is likely a simplified model
of the immune responses to HDM allergens by PBMC,
with only four cytokines taken into account. Other
cytokines such as IL-4, IL-9, IL-25, and IL-33, thymic
stromal lymphopoietin, as well as other cytokine-pro-
ducing cells such as type 2 innate lymphoid cells,
eosinophils, airway epithelial cells, and mast cells
(within tissue) also play important roles in mediating
HDM-induced immune response [20, 28–30].
We have not taken into account the inter-individual
differences in PBMC composition. PBMCs are a mixed
cell population of lymphocytes, monocytes, and den-
dritic cells. Although a mixed cell population is a more
accurate representation of what happens in vivo, know-
ing the composition of the mixed cell population (e.g.
by using cell sorting) might provide further insight into
biological mechanisms. Likewise, we have chosen to
focus on a single early (48 h) time point post-allergen
stimulation, as opposed to later time points at which
cell proliferation and cytokine secretion peaks, in order
to minimize the ‘bystander’ effects of allergen-specific
memory cell-derived cytokines on other cell popula-
tions present within the mixed PBMC cultures. It is pos-
sible that additional information of interest could be
obtained by inclusion of additional time points, but this
is not within the scope of this study.
Our two data sets were obtained from different ages
and geographical areas. To minimize ‘batch effect’, all
samples were shipped to Australia for analysis. To
Cytokine classes
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further reduce heterogeneity, we analysed data from the
two cohorts separately and determined the optimal
transformation of the data before merging the cohorts
for the final clustering. The distribution of cytokine
classes generated from merged data was almost identi-
cal between the two cohorts, suggesting that clustering
was not driven by any one cohort (Table S6).
Interpretation
Our data are suggestive of an interplay between cyto-
kine expression level, cytokine patterns (in particular
IL-13 and IL-5), and clinical outcomes.
Sensitization and immune responses to HDM. Almost
all children in Class 5 were sensitized to HDM, suggest-
ing that high expression of both IL-13 and IL-5 by
HDM-stimulated PBMCs is one of the major pathologi-
cal features of sensitization. However, only 35% of
these children had current wheeze and 28.5% were
asthmatic, implying that HDM sensitization is a risk
factor, but not necessarily per se on the causal pathway
in the pathogenesis of asthma and wheeze. Among
HDM-sensitized children, one-third showed no response
to HDM in the cell culture experiments, a further third
were in Class 5, and the rest were spread across the
remaining four classes. These findings indicate that a
positive ‘allergy test’ can be associated with a broad
range of immunophenotypes.
Asthma and immune response to HDM. Children in
Class 5 (all of whom produced high levels of IL-13, and
almost all produced high levels of IL-5, with some pro-Ta
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duction of IL-10 and IFN-c) had a fivefold increase in
the risk of asthma. After adjustment for multiple test-
ing, none of the other classes were significantly associ-
ated with asthma. Class 4 was significantly associated
with wheeze, and we observed a nonsignificant trend
for the association with asthma. However, among chil-
dren with asthma at a community level, the majority
(one-third) came from the Class 0 (negative for all four
cytokines), almost one-third were in the Class 5, and
the remaining asthmatics were spread across the other
four classes (Table S7).
Interpretation of classes and potential mechanisms. The
large proportion of nonresponders was unlikely the
result of suboptimal culture condition, as culture condi-
tions were stringently maintained across each cohort,
and all analysed subjects had at least one positive cyto-
kine expression under PHA stimulation. In addition, the
proportion of nonresponders was very similar between
the two cohorts, despite age and geographic differences,
implying that HDM-stimulated PBMC responses are
reproducible. It is likely that the frequency of circulat-
ing HDM-specific T memory cells was too low in a sub-
set of HDM-sensitized individuals to elicit a detectable
cytokine response to HDM in PBMC culture; given the
high level of quality control maintained to ensure con-
sistency across all PBMC preparations, cultures and
cytokine measurements within each cohort, this lack of
detected HDM response can be viewed as an indicator
of immune phenotype diversity. Furthermore, though
rigorous, our investigation of immune responses to
HDM exploration was not exhaustive, and there are
pathways outside of those we have studied that contrib-
ute to HDM allergy.
In the current study, we observed highly coordinated
expressions of IL-13 and IL-5 in classes 4 and 5 (with
higher levels seen in Class 5). IL-5 and IL-13 genes are
located in a close proximity in the Th2 locus, which
also contains the IL-4 and the constitutively expressed
Rad50 gene [31]. The entire locus is ~140 kb long and
is similar between humans and mice [32]. In mouse T
cells, remodelling of the chromatin structure within this
region occurs when naive T helper cells differentiate
into mature Th2 cells, an event not observed during
Th1 differentiation [33]. It has been proposed that this
mechanism is important for the coordinated expression
of these two cytokines, also resulting in potentiation of
the expression of the two cytokines [34, 35]. We specu-
late that the co-expressors may have remodelled
chromatin structure within this region.
In PBMC culture, the expression of IL-5, IL-10, IL-13,
and IFN-c is mediated by different cell types. Whereas
IL-5 and IL13 are expressed mainly by the Th2 cells
[36], IL-10 is mainly produced by regulatory T cells
[37] and potentially monocytes [38] and IFN-c by natu-
ral killer and natural killer T cells, as well as CD4 Th1
and CD8 cytotoxic T cells [39]. Children exhibiting dif-
ferent cytokine profiles from in vitro cultured PBMC
not only reflect the possible change of cellular function,
but may also indicate altered cellular composition in
the immune system.
Among the ‘IL-13 and IL-5 high expressors’ (Class 5),
the levels of IL-10 and IFN-c were raised in many of
the children. In our previous studies in the RAINE
cohort in which each cytokine was analysed individu-
ally within HDM-sensitized adolescents, higher levels of
IL-10 and IFN-c were associated with an increased risk
of asthma [20]. In the current analysis, higher IL-10 or
IFN-c was only associated with asthma in the context
of high IL-5 and IL-13 productions; children who pro-
duced IL-10 but no IL-5 (Class 1), or IFN-c but no IL-5
(Class 2) were not at increased risk of asthma. Mecha-
nistically, little is known about what may underlie this
phenomenon. However, in mouse T cells, multiple phys-
ical interactions between the ‘IFN-c locus’ and ‘Th2
locus’ have been observed. Deletion of one of the inter-
action sites (RHS7) significantly delays IFN-c expres-
sion and reduces IL-5 expression [40]. Whether the
co-expression of IL-13, IL-5 and IFN-c was a result of
inter-chromosomal interaction requires further investi-
gation.
The strong association between the co-expression of
IL-13 and IL-5 with asthma or wheeze reflects the func-
tionality of the two cytokines, which has been demon-
strated in mouse aeroallergen challenge models, where
airway remodelling, airway inflammation, and AHR were
dramatically reduced after the knockout of either IL-13
or IL-5 [41, 42]. In addition, as IL-13 is one of the main
inducers for IgE production [43], the high expression
levels of IL-13 in our Class 5 may account for the high
HDM sIgE titres within this class. However, it is notewor-
thy that 28 subjects were not sensitized to HDM, despite
the high expression of both IL-13 and IL-5. Focusing on
these children in the future study might give further
insights into the mechanisms that naturally counterbal-
ance the biological effect of IL-13 and IL-5.
Around a quarter of children were ‘IL-13 single
expressors’ (Class 3 and the majority of Class 2). In
contrast, ‘IL-5 single expressors’ were rare (~2% of the
study population). This implies that most subjects
express IL-5 under the ‘coordinated expression model’.
In contrast, low levels of IL-13 expression without
activating IL-5 were common, suggesting two different
expression mechanisms between ‘IL-5/IL-13 co-expres-
sors’ and ‘IL-13 single expressors’. The IL-13 and IFN-c
coexpressors (Class 2) showed much lower risks for
HDM sensitization compared to Class 3, where the
majority did not express IFN-c. In the sensitization
model, mice receiving recombinant IFN-c or intrave-
nous IFN-c gene showed reduced antigen-induced
© 2015 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd., 45 : 1801–1811
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eosinophillic airway infiltration and inhibited develop-
ment of AHR, suggesting a possible protective role for
IFN-c [44, 45].
Children in Class1 (‘IL-10 expressors’) had a rela-
tively low risk of HDM sensitization, asthma, and
wheeze. This is biologically plausible and may reflect
the immune-modulatory role of IL-10. Of note,
although the nonresponders (Class 0) had low risk of
HDM sensitization as a group, at a population level
~one-third of HDM-sensitized children came from this
subgroup; we observed similar findings for wheeze/
asthma (Table S7).
Conclusion
Using model-based clustering approach, we identified
several distinct patterns of PBMC cytokine response to
HDM allergens. We observed interplay between cyto-
kine levels, the expression patterns, and the manifesta-
tion of clinical outcomes. High expression of both IL-
13 and IL-5 by HDM-stimulated PBMC was highly
associated with HDM sensitization (ascertained by SPT
or mite IgE). However, a third of HDM-sensitized chil-
dren were in the nonresponder group, suggesting the
presence of other mechanisms of HDM sensitization.
Even in Class 5, the majority of children did not have
current asthma or wheeze, despite the high prevalence
of HDM sensitization. The heterogeneity of cytokine
patterns shown in this study may have important
implications for the efficacy of asthma and allergy
treatment approaches that block action of single cyto-
kines.
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